基本信息
views: 2
Career Trajectory
Bio
Dr. Leiter has several research interests including clinical trials on the prevention of atherosclerosis, especially in diabetes, and the dietary and pharmacologic treatment of diabetes mellitus, hyperlipidemia, hypertension, and obesity. He has over 800 publications in peer-reviewed journals. He was an investigator in many of the landmark diabetes trials including the DCCT, ACCORD, and ADVANCE and has had leadership roles in many past and ongoing outcome trials in both the diabetes and lipid areas. In 2018, 2019, and 2020 he was a Clarivate Analytics Top 1% Highly Cited Researcher.
Research Interests
Papers共 1026 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yu Mi Kang, Giorgio E. M. Melloni,Avivit Cahn,Itamar Raz,Filipe Moura,Deepak L. Bhatt,Silvio E. Inzucchi,Lawrence A. Leiter,Darren K. McGuire,John Wilding, Ingrid A. Gause-Nilsson,Jan Oscarsson, Nicholas Marston, Christian T. Ruff, Marc S. Sabatine,Stephen D. Wiviott
DIABETES (2024)
Diabetes Therapyno. 9 (2024): 1-69
MEDno. 7 (2024)
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGYno. 13 (2024): 378-378
Journal of the American College of Cardiologyno. 13 (2024): 2077
Diabetes, obesity & metabolism/Diabetes, obesity and metabolism (2024)
Journal of the American College of Cardiologyno. 13 (2024): 1888
DIABETES OBESITY & METABOLISM (2024)
Load More
Author Statistics
#Papers: 1026
#Citation: 63706
H-Index: 123
G-Index: 235
Sociability: 9
Diversity: 0
Activity: 9
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn